Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
100.58 -0.01 / -0.01%
Data as of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
100.45 -0.13 / -0.13%
 
Volume: 223.1K
Buy Gilead Sciences
9:32am / TheStreet.com
Trading Activity
Nov 14 / StockTwits
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
Nov 20 / Zacks.com
Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Nov 13 / Zacks.com
Biotech's 3 Most Influential CEOs
Nov 20 / MotleyFool.com
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Nov 12 / Zacks.com
CNBC's Stock Pops & Drops From November 19
Nov 20 / Benzinga
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bank...
Nov 12 / Zacks.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 / Zacks.com
This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Nov 12 / MotleyFool.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in th...
Nov 19 / Zacks.com
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
Nov 11 / Zacks.com
Stock Market News for November 19, 2014 - Market News
Nov 19 / Zacks.com
Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Nov 11 / Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
Nov 18 / TheStreet.com
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog
Nov 11 / Zacks.com
Front Runners: TerraForm Power (TERP), Virgin America (VA), Abengoa SA (ABGB), Gilead...
Nov 18 / Investing Channel
Stock Market News for November 11, 2014 - Market News
Nov 11 / Zacks.com
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide
Nov 18 / TheStreet.com
Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much
Nov 11 / MotleyFool.com
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for...
Nov 18 / TheStreet.com
Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
Nov 10 / Zacks.com
Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More
Nov 17 / TheStreet.com
3 Drugs That Make Gilead Sciences' Harvoni Look Cheap
Nov 10 / MotleyFool.com
3 Stocks Reiterated As A Buy: GE, GILD, PG
Nov 17 / TheStreet.com
October jitters are just a taste things to come
Nov 10 / FT.com
AZN, PFE And GILD, 3 Drugs Stocks Pushing The Industry Lower
Nov 17 / TheStreet.com
5 Prescription Drugs Selling Like Hot Cakes
Nov 09 / MotleyFool.com
Stock Market News for November 17, 2014 - Market News
Nov 17 / Zacks.com
Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
Nov 09 / Zacks.com
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 / MotleyFool.com
Gilead Sciences Popular Amongst Latest 13F Filers
Oct 31 / HoldingsChannel.com
3 Stocks the Smartest Investors Are Buying Right Now
Nov 17 / MotleyFool.com
Electronic Arts climbs on strong earnings
Oct 29 / FT.com
Healthy Returns From The Healthcare Sector
Nov 16 / Investing Channel
Gilead's latest hepatitis C drug breaks US sales records
Oct 28 / FT.com
These Two Look Tempting
Nov 16 / TheStreet.com
Friday Sector Leaders: Healthcare, Utilities
Oct 24 / TheOnlineInvestor.com
The Fab 5 Update
Nov 15 / StockTwits
Progress against Aids spurs GSK plan to float ViiV Healthcare
Oct 24 / FT.com
Julian Robertson's Tiger Management 13F Reveals Huge Alibaba Stake
Nov 15 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.